Collier Kathryn J
Insider CIK 1737436 · RGLS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 60,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 4,650 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 9,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 75,565 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2025-06-17 | 2025-06-18 | 2,604 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2025-06-17 | 2025-06-18 | 2,325 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2025-06-17 | 2025-06-18 | 2,325 | $8.80 | $20.5K | 62,915 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2025-06-17 | 2025-06-18 | 2,604 | $9.90 | $25.8K | 65,240 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2025-06-16 | 2025-06-18 | 1,396 | — | $0 | 2,604 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2025-06-16 | 2025-06-18 | 1,396 | $9.90 | $13.8K | 67,844 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-04-30 | 2025-04-30 | 62,500 | — | $0 | 69,240 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2024-07-25 | 2024-07-29 | 4,000 | $1.82 | $7.3K | 6,740 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-16 | 2024-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-06-13 | 2023-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 90,000 | — | $0 | 90,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-06-14 | 2021-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 23,250 | — | $0 | 23,250 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 46,500 | — | $0 | 46,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2018-11-16 | 2018-11-19 | 7,100 | $1.41 | $10.0K | 27,596 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 3,125 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 4,583 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2018-11-12 | 2018-11-13 | 9,166 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2018-11-12 | 2018-11-13 | 16,874 | — | $0 | 20,496 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2018-06-05 | 2018-06-05 | 7,695 | $0.74 | $5.7K | 7,695 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-05-17 | 2018-05-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-04-14 | 2018-04-17 | 110,000 | — | $0 | 110,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2018-04-14 | 2018-04-17 | 60,234 | $0.64 | $38.5K | 60,234 | SEC↗ |